Didier Junquéro

1.3k total citations
32 papers, 1.1k citations indexed

About

Didier Junquéro is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Didier Junquéro has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Didier Junquéro's work include Nitric Oxide and Endothelin Effects (8 papers), Cholesterol and Lipid Metabolism (8 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Didier Junquéro is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Cholesterol and Lipid Metabolism (8 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Didier Junquéro collaborates with scholars based in France, United States and Germany. Didier Junquéro's co-authors include Timothy Scott‐Burden, V B Schini, Paul M. Vanhoutte, André Delhon, P. M. Vanhoutte, Yves Rival, Françis C. Colpaert, Kenneth K. Wu, Helen MacGill Hughes and Chantal M. Boulanger and has published in prestigious journals such as Circulation Research, The Journal of Physiology and Biochemical and Biophysical Research Communications.

In The Last Decade

Didier Junquéro

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Didier Junquéro France 19 511 415 284 218 186 32 1.1k
S. Murota Japan 19 342 0.7× 436 1.1× 230 0.8× 149 0.7× 154 0.8× 48 1.2k
Lourdes Sánchez de Miguel Spain 22 543 1.1× 362 0.9× 134 0.5× 458 2.1× 135 0.7× 32 1.3k
Ferruccio Berti Italy 21 559 1.1× 307 0.7× 167 0.6× 312 1.4× 223 1.2× 55 1.3k
Voahanginirina Randriamboavonjy Germany 22 338 0.7× 539 1.3× 221 0.8× 241 1.1× 93 0.5× 42 1.3k
Winfried Göettsch Germany 15 464 0.9× 310 0.7× 112 0.4× 389 1.8× 141 0.8× 30 1.1k
Mohammed El Mabrouk Canada 15 267 0.5× 597 1.4× 143 0.5× 341 1.6× 97 0.5× 24 1.1k
Denise McDonald United Kingdom 17 555 1.1× 379 0.9× 115 0.4× 300 1.4× 147 0.8× 34 1.5k
Yanxing Chen United States 18 302 0.6× 679 1.6× 192 0.7× 311 1.4× 256 1.4× 36 1.4k
Mark Hartmann Germany 9 696 1.4× 564 1.4× 198 0.7× 374 1.7× 105 0.6× 13 1.5k
Monique David‐Dufilho France 19 428 0.8× 437 1.1× 109 0.4× 222 1.0× 144 0.8× 49 1.1k

Countries citing papers authored by Didier Junquéro

Since Specialization
Citations

This map shows the geographic impact of Didier Junquéro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Junquéro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Junquéro more than expected).

Fields of papers citing papers by Didier Junquéro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Junquéro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Junquéro. The network helps show where Didier Junquéro may publish in the future.

Co-authorship network of co-authors of Didier Junquéro

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Junquéro. A scholar is included among the top collaborators of Didier Junquéro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Junquéro. Didier Junquéro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Latil, Alain, et al.. (2012). Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP‐1/CCL2 and VCAM‐1, in vitro. British Journal of Urology. 110(6b). E301–7. 43 indexed citations
2.
Rival, Yves, L. Puech, F. Lestienne, et al.. (2009). PPAR activators and COX inhibitors selectively block cytokine-induced COX-2 expression and activity in human aortic smooth muscle cells. European Journal of Pharmacology. 606(1-3). 121–129. 6 indexed citations
3.
Junquéro, Didier & Yves Rival. (2005). Syndrome métabolique : quelle définition pour quel(s) traitement(s) ?. médecine/sciences. 21(12). 1045–1053. 22 indexed citations
4.
Rival, Yves, et al.. (2004). Cardiovascular Drugs Inhibit MMP-9 Activity from Human THP-1 Macrophages. DNA and Cell Biology. 23(5). 283–292. 21 indexed citations
5.
Rival, Yves, L. Puech, F. Lestienne, et al.. (2004). Human Adipocyte Fatty Acid-Binding Protein (aP2) Gene Promoter-Driven Reporter Assay Discriminates Nonlipogenic Peroxisome Proliferator-Activated Receptor γ Ligands. Journal of Pharmacology and Experimental Therapeutics. 311(2). 467–475. 43 indexed citations
6.
Pilon, Antoine, Geneviève Martin, Didier Junquéro, et al.. (2003). Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1631(3). 218–228. 30 indexed citations
7.
Wurch, Thierry, Didier Junquéro, André Delhon, & Petrus J. Pauwels. (2002). Pharmacological analysis of wild-type α, γ and δ subtypes of the human peroxisome proliferator-activated receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 365(2). 133–140. 27 indexed citations
8.
Rival, Yves, et al.. (2002). Anti-Atherosclerotic Properties of the Acyl-coenzyme A:Cholesterol Acyltransferase Inhibitor F 12511 in Casein-Fed New Zealand Rabbits. Journal of Cardiovascular Pharmacology. 39(2). 181–191. 18 indexed citations
12.
Gotteland, Jean‐Pierre, et al.. (1998). Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: A new type of potent squalene epoxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(11). 1337–1342. 12 indexed citations
13.
Augè, Nathalie, Jean‐Loup Bascands, Marie‐Thérèse Pieraggi, et al.. (1996). Mildly Oxidized LDL Evokes a Sustained Ca 2+ -Dependent Retraction of Vascular Smooth Muscle Cells. Circulation Research. 79(4). 871–880. 21 indexed citations
14.
Gotteland, Jean‐Pierre, et al.. (1995). (Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors. Journal of Medicinal Chemistry. 38(17). 3207–3216. 27 indexed citations
15.
Junquéro, Didier, V B Schini, Timothy Scott‐Burden, & P. M. Vanhoutte. (1992). Transforming growth factor-beta 1 inhibits L-arginine-derived relaxing factor(s) from smooth muscle cells. American Journal of Physiology-Heart and Circulatory Physiology. 262(6). H1788–H1795. 8 indexed citations
16.
Junquéro, Didier, Valérie B. Schini, & Paul M. Vanhoutte. (1991). Indapamide potentiates the endothelium-dependent production of cyclic guanosine monophosphate by bradykinin in the canine femoral artery. American Heart Journal. 122(4). 1204–1209. 8 indexed citations
17.
Schini, V B, Didier Junquéro, Timothy Scott‐Burden, & Paul M. Vanhoutte. (1991). Interleukin-1 β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochemical and Biophysical Research Communications. 176(1). 114–121. 88 indexed citations
18.
Bonne, C., et al.. (1991). [Effect of retinoids on the growth of corneal endothelial cells in culture].. PubMed. 4(1). 84–7. 1 indexed citations
19.
Junquéro, Didier, et al.. (1990). Retinoids enhance the number of EGF receptors in corneal endothelial cells. Experimental Eye Research. 51(1). 49–53. 4 indexed citations
20.
Dornand, Jacques, Nicole Bernad, Didier Junquéro, et al.. (1990). LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities. Inflammation Research. 30(3-4). 403–411. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026